Seite wählen

What Are the Costs of Developing New Drugs?

Michael Schlander and Karla Hernandez-Villafuerte have shed light on the systematic analysis of the actual development costs of new drugs for common and rare diseases (orphan drugs) conducted by cancer researchers and health economists from the German Cancer Research...

New Treatment Approach for Cardiovascular Diseases

A team of scientists led by Professor Dr. Philip Wenzel and Prof. Dr. Thomas Münzel from the Center for Cardiology at the University Medical Center Mainz recently used data from the Gutenberg Health Study (GHS) to show that people may respond to improved drug therapy...

Revolutionary 3D Structural Analysis of Proteins

DeepMind, founded in 2010 and now part of Google, specializes in artificial intelligence (AI) programming. Recently, DeepMind achieved a breakthrough in protein structure elucidation, as researchers previously knew only 17 percent of amino acids (the smallest basic...

US Study on Diet for Migraine

In a study of 182 migraine patients at the University of North Carolina School of Medicine, patients were evaluated for severity and frequency of headaches after eating certain foods for 16 weeks. In fact, scientists suspected that an imbalance of omega-3 to omega-6...

Robot development in Lübeck

In Lübeck, various scientists have collaborated on developing a magnetic micro-robot smaller than a grain of rice. The Institute for Medical Technology at the University of Lübeck, the Fraunhofer Institute for Individualised and Cell-based Medical Technology IMTE, and...